{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:37:12Z","timestamp":1793317032653,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.xphs.2023.10.016","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T02:36:31Z","timestamp":1697250991000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Fifty Years of Unraveling the Clinical Pharmacology of Corticosteroids"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5631-2228","authenticated-orcid":false,"given":"Kathryn E.","family":"Kyler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6911-3199","authenticated-orcid":false,"given":"Stanley J.","family":"Szefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7728","key":"10.1016\/j.xphs.2023.10.016_bib0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0140-6736(71)92738-3","article-title":"Program bcds. Prednisone side-effects and serum-protein levels: a collaborative study","volume":"298","author":"Lewis","year":"1971","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-4347(00)81514-5","article-title":"Corticosteroid analysis in biological fluids by high-performance liquid chromatography","volume":"162","author":"Rose","year":"1979","journal-title":"J Chromatogr"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0003","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0378-4347(00)83342-3","article-title":"Analysis of cortisol, methylprednisolone, and methylprednisolone hemisuccinate. Absence of effects of troleandomycin on ester hydrolysis","volume":"305","author":"Ebling","year":"1984","journal-title":"J Chromatogr"},{"key":"10.1016\/j.xphs.2023.10.016_bib0004","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0378-4347(00)80658-1","article-title":"Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma","volume":"432","author":"Kong","year":"1988","journal-title":"J Chromatogr"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0378-4347(91)80307-X","article-title":"Simultaneous analysis of prednisone, prednisolone and their major hydroxylated metabolites in urine by high-performance liquid chromatography","volume":"567","author":"Garg","year":"1991","journal-title":"J Chromatogr"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-4347(94)00218-5","article-title":"Fifteen years of operation of a high-performance liquid chromatographic assay for prednisolone, cortisol and prednisone in plasma","volume":"658","author":"Jusko","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"10","key":"10.1016\/j.xphs.2023.10.016_bib0007","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jps.2600701019","article-title":"Blood collection technique: no effect on in vitro protein binding of prednisolone","volume":"70","author":"Rocci","year":"1981","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0008","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0022-3476(79)80261-9","article-title":"Prednisolone pharmacokinetics in relation to dose","volume":"94","author":"Rose","year":"1979","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0009","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF01060885","article-title":"Dose dependent pharmacokinetics of prednisone and prednisolone in man","volume":"9","author":"Rose","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00541537","article-title":"Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults","volume":"30","author":"Szefler","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0011","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/bdd.2510150208","article-title":"Bioavailability and reversible metabolism of prednisone and prednisolone in man","volume":"15","author":"Garg","year":"1994","journal-title":"Biopharm Drug Dispos"},{"issue":"8","key":"10.1016\/j.xphs.2023.10.016_bib0012","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jps.2600690831","article-title":"Serum protein binding of prednisolone in four species","volume":"69","author":"Rocci","year":"1980","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0013","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-2952(82)90172-1","article-title":"Prednisolone binding to albumin and transcortin in the presence of cortisol","volume":"31","author":"Rocci","year":"1982","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0014","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-4731(83)90087-0","article-title":"Binding of prednisolone to alpha 1-acid glycoprotein","volume":"18","author":"Milsap","year":"1983","journal-title":"J Steroid Biochem"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/jps.2600730617","article-title":"Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis","volume":"73","author":"Boudinot","year":"1984","journal-title":"J Pharm Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0016","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0022-4731(84)90288-7","article-title":"Plasma protein binding interaction of prednisone and prednisolone","volume":"21","author":"Boudinot","year":"1984","journal-title":"J Steroid Biochem"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0017","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1993.167","article-title":"Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics","volume":"54","author":"Lew","year":"1993","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.016_bib0018","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/00912700122012733","article-title":"Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race","volume":"41","author":"Magee","year":"2001","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0019","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-69-3-493","article-title":"Steroid resistance in bronchial asthma","volume":"69","author":"Schwartz","year":"1968","journal-title":"Ann Intern Med"},{"issue":"6274","key":"10.1016\/j.xphs.2023.10.016_bib0020","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.282.6274.1419","article-title":"Corticosteroid resistance in chronic asthma","volume":"282","author":"Carmichael","year":"1981","journal-title":"Br Med J Clin Res Ed"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0021","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/jps.2600680529","article-title":"Hydrocortisone stability in human feces","volume":"68","author":"MacKichan","year":"1979","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0022","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/clpt.1980.159","article-title":"Bioavailability of hydrocortisone retention enemas in relation to absorption kinetics","volume":"28","author":"Lima","year":"1980","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0023","first-page":"232","article-title":"Bioavailability of hydrocortisone retention enemas in normal subjects","volume":"73","author":"Lima","year":"1980","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0024","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0091-6749(80)90115-3","article-title":"Prednisolone disposition in steroid-dependent asthmatics","volume":"66","author":"Rose","year":"1980","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0091-6749(81)90060-9","article-title":"Prednisolone disposition in steroid-dependent asthmatic children","volume":"67","author":"Rose","year":"1981","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.016_bib0026","first-page":"876","article-title":"Rapid methylprednisolone clearance in a patient with cystic fibrosis","volume":"22","author":"Green","year":"1988","journal-title":"Drug Intell Clin Pharm"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0027","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0022-3476(05)80250-1","article-title":"Altered prednisolone pharmacokinetics in patients with cystic fibrosis","volume":"120","author":"Dove","year":"1992","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0028","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00605993","article-title":"Disposition of pulse dose methylprednisolone in adult and paediatric patients with the nephrotic syndrome","volume":"23","author":"Assael","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0029","first-page":"159","article-title":"Effect on nephrotic syndrome on absorption and disposition of prednisolone in children","volume":"3","author":"Rocci","year":"1982","journal-title":"Int J Pediatr Nephrol"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0030","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/clpt.1984.263","article-title":"Prednisolone disposition in obese men","volume":"36","author":"Milsap","year":"1984","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0031","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/clpt.1991.64","article-title":"Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity","volume":"49","author":"Dunn","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.xphs.2023.10.016_bib0032","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/j.1552-4604.1993.tb01955.x","article-title":"Pharmacokinetics of methylprednisolone hemisuccinate and methylprednisolone in chronic liver disease","volume":"33","author":"Ludwig","year":"1993","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0033","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1097\/00007890-198912000-00013","article-title":"Methylprednisolone disposition in renal transplant recipients receiving triple-drug immunosuppression","volume":"48","author":"Tornatore","year":"1989","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00045391-199406000-00009","article-title":"The Pharmacokinetics and Pharmacodynamics of Methylprednisolone in Chronic Renal Failure","volume":"1","author":"Milad","year":"1994","journal-title":"Am J Ther"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/j.1875-9114.1998.tb03821.x","article-title":"Methylprednisolone disposition kinetics in patients with acute spinal cord injury","volume":"18","author":"Segal","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0036","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/j.1875-9114.1990.tb02547.x","article-title":"Pharmacokinetics of methylprednisolone sodium succinate and methylprednisolone in patients undergoing cardiopulmonary bypass","volume":"10","author":"Kong","year":"1990","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0037","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0021-8707(70)90124-3","article-title":"The use of macrolide antibiotic substances in the treatment of asthma","volume":"45","author":"Itkin","year":"1970","journal-title":"J Allergy"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0038","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0091-6749(74)90027-X","article-title":"Troleandomycin: effectiveness in steroid-dependent asthma and bronchitis","volume":"54","author":"Spector","year":"1974","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0039","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0091-6749(80)90004-4","article-title":"The effect of troleandomycin on methylprednisolone elimination","volume":"66","author":"Szefler","year":"1980","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0040","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/clpt.1982.143","article-title":"Dose- and time-related effect of troleandomycin on methylprednisolone elimination","volume":"32","author":"Szefler","year":"1982","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0041","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0091-6749(82)90121-X","article-title":"Steroid-specific and anticonvulsant interaction aspects of troleandomycin-steroid therapy","volume":"69","author":"Szefler","year":"1982","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01059339","article-title":"Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokinetics","volume":"9","author":"Rose","year":"1981","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0043","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1210\/jcem-56-4-702","article-title":"Prednisolone Disposition and Protein Binding in Oral Contraceptive Users*","volume":"56","author":"Boekenoogen","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0044","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/clpt.1986.114","article-title":"Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion","volume":"39","author":"Glynn","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0045","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/clpt.1987.179","article-title":"Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol","volume":"42","author":"Kandrotas","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0046","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/clpt.1991.66","article-title":"Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone","volume":"49","author":"Yamashita","year":"1991","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0047","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1378\/chest.99.3.670","article-title":"Erythromycin reduces the severity of bronchial hyperresponsiveness in asthma","volume":"99","author":"Miyatake","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.xphs.2023.10.016_bib0048","unstructured":"Hahn D.L. lntracellular pathogens and their role in asthma: chlamydia pneumoniae in adult patients."},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0049","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0091-6749(78)90088-X","article-title":"Enhancement by oleandomycin of the inhibitory effect of methylprednisolone on phytohemagglutinin-stimulated lymphocytes","volume":"62","author":"Ong","year":"1978","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0050","doi-asserted-by":"crossref","first-page":"PL25","DOI":"10.1016\/0024-3205(93)90154-U","article-title":"Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes","volume":"52","author":"Konno","year":"1993","journal-title":"Life Sci"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0051","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1164\/rccm.200212-1437OC","article-title":"In vivo and in vitro effects of macrolide antibiotics on mucus secretion in airway epithelial cells","volume":"168","author":"Shimizu","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.016_bib0052","article-title":"Macrolides versus placebo for chronic asthma","author":"Undela","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0053","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70175-2","article-title":"Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy","volume":"103","author":"Fost","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2023.10.016_bib0054","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0091-6749(83)90049-0","article-title":"Inhibition of methylprednisolone elimination in the presence of erythromycin therapy","volume":"72","author":"LaForce","year":"1983","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0055","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0091-6749(95)70073-0","article-title":"Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy","volume":"95","author":"Pincus","year":"1995","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0056","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/clpt.1987.173","article-title":"Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy","volume":"42","author":"Bartoszek","year":"1987","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.xphs.2023.10.016_bib0057","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/BF01062961","article-title":"Two-compartment basophil cell trafficking model for methylprednisolone pharmacodynamics","volume":"19","author":"Wald","year":"1991","journal-title":"J Pharmacokinet Biopharm"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0058","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/0091-6749(90)90051-5","article-title":"Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man","volume":"85","author":"Reiss","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0059","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/clpt.1989.196","article-title":"Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects","volume":"46","author":"Kong","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0060","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/BF01064420","article-title":"Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man","volume":"20","author":"Wald","year":"1992","journal-title":"J Pharmacokinet Biopharm"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0061","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF02353790","article-title":"Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking","volume":"22","author":"Milad","year":"1994","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0062","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/BF01062461","article-title":"Pharmacoimmunodynamics of Methylprednisolone: trafficking of Helper T Lymphocytes","volume":"20","author":"Fisher","year":"1992","journal-title":"J Pharmacokinet Biopharm"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0063","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/clpt.1992.80","article-title":"Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm","volume":"51","author":"Fisher","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.xphs.2023.10.016_bib0064","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1020974408657","article-title":"Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone","volume":"27","author":"Chow","year":"1999","journal-title":"J Pharmacokinet Biopharm"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.016_bib0065","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/0091270003258651","article-title":"Dose equivalency evaluation of major corticosteroids: pharmacokinetics and cell trafficking and cortisol dynamics","volume":"43","author":"Mager","year":"2003","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0066","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF01061691","article-title":"Comparison of four basic models of indirect pharmacodynamic responses","volume":"21","author":"Dayneka","year":"1993","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"10.1016\/j.xphs.2023.10.016_bib0067","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/clpt.1994.155","article-title":"Physiologic indirect response models characterize diverse types of pharmacodynamic effects","volume":"56","author":"Jusko","year":"1994","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0068","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/pr.119.018101","article-title":"Transitioning from basic toward systems pharmacodynamic models: lessons from corticosteroids","volume":"72","author":"Ayyar","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"7","key":"10.1016\/j.xphs.2023.10.016_bib0069","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/jps.10402","article-title":"Relative immunosuppressive potency of therapeutic corticosteroids measured by whole blood lymphocyte proliferation","volume":"92","author":"Mager","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.xphs.2023.10.016_bib0070","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13577","article-title":"Anti-inflammatory effects of dexamethasone in COVID-19 patients: translational population PK\/PD modeling and simulation","author":"\u015awierczek","year":"2023","journal-title":"Clin Transl Sci"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0071","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.122.001477","article-title":"Pharmacokinetic\/pharmacodynamic modeling of dexamethasone anti-inflammatory and immunomodulatory effects in LPS-challenged rats: a model for cytokine release syndrome","volume":"384","author":"\u015awierczek","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0072","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10928-020-09730-z","article-title":"Population pharmacokinetic modeling of intramuscular and oral dexamethasone and betamethasone in Indian women","volume":"48","author":"Krzyzanski","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"10.1016\/j.xphs.2023.10.016_bib0073","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10928-021-09755-y","article-title":"Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women","volume":"48","author":"Krzyzanski","year":"2021","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0074","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/jpet.119.257527","article-title":"Modeling corticosteroid pharmacokinetics and pharmacodynamics, part ii: sex differences in methylprednisolone pharmacokinetics and corticosterone suppression","volume":"370","author":"Ayyar","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.xphs.2023.10.016_bib0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.119.257543","article-title":"Modeling corticosteroid pharmacokinetics and pharmacodynamics, part III: estrous cycle and estrogen receptor-dependent antagonism of glucocorticoid-induced leucine zipper (GILZ) enhancement by corticosteroids","volume":"370","author":"Ayyar","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.016_bib0076","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11095-018-2483-5","article-title":"Modeling sex differences in anti-inflammatory effects of dexamethasone in arthritic rats","volume":"35","author":"Song","year":"2018","journal-title":"Pharm Res"},{"issue":"11","key":"10.1016\/j.xphs.2023.10.016_bib0077","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/gerona\/glac042","article-title":"Is sex as a biological variable still being ignored in preclinical aging research?","volume":"77","author":"Carmody","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923004240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354923004240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:45:48Z","timestamp":1758361548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354923004240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0022354923004240"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2023.10.016","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fifty Years of Unraveling the Clinical Pharmacology of Corticosteroids","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2023.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}